FDA places hold on Zolgensma trials due to safety concerns
US FDA places a hold on a clinical study testing Novartis’ Zolgensma in patients with SMA Type 2, after information provided to the authorities by AveXis.
Archives for October 31, 2019
Germany seen as the leader of European pharma industry
Research ranks Germany as the leading nation within Europe due to the high rating of its finished production manufacturing and potential for growth.
Amgen joins neuroscience exodus
In third quarter financials, Amgen announces that it will end its R&D efforts in neuroscience to focus on diseases with a ‘large public health impact.